The Role of Insulin in Human Brain Glucose Metabolism
An 18Fluoro-Deoxyglucose Positron Emission Tomography Study
- Emma M. Bingham1,
- David Hopkins2,
- Diarmuid Smith1,
- Andrew Pernet1,
- William Hallett3,
- Laurence Reed4,
- Paul K. Marsden3 and
- Stephanie A. Amiel1
- 1GKT School of Medicine, King’s College Hospital, London, U.K
- 2Department Diabetes, Central Middlesex Hospital, London, U.K
- 3PET Centre, St Thomas’ Hospital, London, U.K
- 4Institute of Psychiatry, Maudsley Hospital, London, U.K
Abstract
The effect of basal insulin on global and regional brain glucose uptake and metabolism in humans was studied using 18-fluorodeoxyglucose and positron emission tomography (FDG-PET). Eight healthy male volunteers aged 49.3 ± 5.1 years were studied twice in random order. On each occasion, they received an infusion of 0.1 mg · kg−1 · min−1 somatostatin to suppress endogenous insulin production. In one study 0.3 mU · kg−1 · min−1 insulin was infused to replace basal circulating insulin levels, and in the other study a saline infusion was used as control. We sought stimulatory effects of basal insulin on brain glucose metabolism particularly in regions with deficiencies in the blood-brain barrier and high density of insulin receptors. Insulin levels were 27.07 ± 1.3 mU/l with insulin replacement and 3.51 ± 0.4 mU/l without (P = 0.001). Mean global rate of brain glucose utilization was 0.215 ± 0.030 mmol · kg−1 · min−1 without insulin and 0.245 ± 0.021 mmol · kg−1 · min−1 with insulin (P = 0.008, an average difference of 15.3 ± 12.5%). Regional analysis using statistical parametric mapping showed that the effect of basal insulin was significantly less in the cerebellum (Z = 5.53, corrected P = 0.031). We conclude that basal insulin has a role in regulating global brain glucose uptake in humans, mostly marked in cortical areas.
Footnotes
-
Address correspondence and reprint requests to Dr. Emma Bingham, GKT School of Medicine, King’s College Hospital, London SE5 9PJ, U.K. E-mail: emma.bingham{at}kcl.ac.uk.
Received for publication 19 March 2002 and accepted in revised form 28 August 2002.
CSF, cerebrospinal fluid; CV, coefficient of variation; FDG, 18-fluorodeoxyglucose; LC, lumped constant; MRI, magnetic resonance image; PET, positron emission tomography; SPM, statistical parametric mapping; ROI, region of interest.
- DIABETES














